Registry of the Spanish Network for Systemic Sclerosis: Survival, Prognostic Factors, and Causes of Death.

Autor: Simeón-Aznar CP; From the Department of Internal Medicine, Hospital Valld'Hebron (CPS-A, VF-P, MV-T); Department of Internal Medicine, Hospital Parc Taulí, Sabadell (CT-V); Department of Autoimmune Diseases, Hospital Clinic (GE-G, MR-C); Laboratori of Computacional Medicine, Bioestatistics Unit, Universitat Autònoma de Barcelona, Bellaterra, Barcelona (MC-G); Unit of Connective Tissue Diseases, Department of Internal Medicine, Hospital Virgen del Rocio, Sevilla (FJG-H, MJC-P, JS-R); Unit of Autoimmune Systemic Diseases, Department of Internal Medicine, Hospital Clínico San Cecilio, Granada (JLC-R, NO-C); Department of Internal Medicine, Hospital de Cruces, Galdakano, Bilbao (MVE-A); Department of Internal Medicine, Hospital de Cabueñes, Gijón (LT-M); Department of Internal Medicine, Hospital Universitario Central de Asturias, Oviedo (LC-M); Department of Internal Medicine, Hospital Miguel Servet, Zaragoza (LS-C, JV-M); Department of Internal Medicine, Hospital Carlos Haya, Málaga (MTC-G, ER-G); Department of Internal Medicine, Hospital Son Espases, Palma de Mallorca (EME-M, LP-F); Department of Internal Medicine, Hospital Virgen de las Nieves, Granada (NN-N, JAV-H); Department of Internal Medicine, Hospital San Agustín, Avilés (RGT); Department of Internal Medicine, Hospital La Fe, Valencia (GS-C); and Department of Internal Medicine, Hospital La Paz, Madrid (JJR-B), Systemic Autoimmune Diseases Group (GEAS), Spanish Scleroderma Study Group (SSSG), Spanish Society of Internal Medicine, Spain., Fonollosa-Plá V, Tolosa-Vilella C, Espinosa-Garriga G, Campillo-Grau M, Ramos-Casals M, García-Hernández FJ, Castillo-Palma MJ, Sánchez-Román J, Callejas-Rubio JL, Ortego-Centeno N, Egurbide-Arberas MV, Trapiellla-Martínez L, Caminal-Montero L, Sáez-Comet L, Velilla-Marco J, Camps-García MT, de Ramón-Garrido E, Esteban-Marcos EM, Pallarés-Ferreres L, Navarrete-Navarrete N, Vargas-Hitos JA, Torre RG, Salvador-Cervello G, Rios-Blanco JJ, Vilardell-Tarrés M

Publikováno v: Medicine [Medicine (Baltimore)] 2015 Oct; Vol. 94 (43), pp. e1728.

Impaired sexual function in women with systemic lupus erythematosus: a cross-sectional study.

Autor: García Morales M; Systemic Autoimmune Diseases Unit, San Cecilio Hospital, Granada, Spain. marta1721@hotmail.com, Callejas Rubio JI, Peralta-Ramírez MI, Henares Romero LJ, Ríos Fernández R, Camps García MT, Navarrete Navarrete N, Ortego Centeno N

Publikováno v: Lupus [Lupus] 2013 Sep; Vol. 22 (10), pp. 987-95.

Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status.

Autor: Simeón-Aznar CP; Department of Internal Medicine, Hospital Valld'Hebron, Barcelona, Spain. cpsimeon@vhebron.net, Fonollosa-Plá V, Tolosa-Vilella C, Espinosa-Garriga G, Ramos-Casals M, Campillo-Grau M, García-Hernández FJ, Castillo-Palma MJ, Sánchez-Román J, Callejas-Rubio JL, Ortego-Centeno N, Egurbide-Arberas MV, Trapiellla-Martínez L, Gallego-Villalobos M, Sáez-Comet L, Velilla-Marco J, Camps-García MT, de Ramón-Garrido E, Esteban Marcos EM, Pallarés-Ferreres L, Hidalgo-Tenorio C, Sabio-Sánchez JM, Gómez-de la Torre R, Salvador-Cervello G, Rios-Blanco JJ, Gil-Aguado A, Vilardell-Tarrés M

Publikováno v: Seminars in arthritis and rheumatism [Semin Arthritis Rheum] 2012 Jun; Vol. 41 (6), pp. 789-800. Date of Electronic Publication: 2011 Dec 12.

[Hemophagocytic syndrome in adult Still disease after initiation of sulfasalazine].

Autor: Pérez-De Pedro I, Miranda-Candón I, Camps-García MT, Gómez-Huelgas R

Publikováno v: Revista clinica espanola [Rev Clin Esp] 2010 May; Vol. 210 (5), pp. 251-2. Date of Electronic Publication: 2010 Apr 08.

[Rituximab as treatment for thrombocytopenic thrombotic purpura associated with systemic lupus erythematosus].

Autor: López Carmona D, Pérez de Pedro I, de Ramón E, Camps García MT

Publikováno v: Medicina clinica [Med Clin (Barc)] 2007 Dec 01; Vol. 129 (20), pp. 797-8.